SA49 Virological Suppression in People Living with HIV-1 (PLWH) Receiving Dolutegravir/Lamivudine Was High and Similar across Age Groups Despite Older Plwh Having Increased Rates of Comorbidities and Polypharmacy (TANDEM SUBGROUP)
Abstract
Authors
A. Brogan J. Slim G. Verdier G. Harper K. Mycock H. Wallis C. Donovan